IL1B and gout: Previous reports have shown that AM had anti-inflammation, anti-oxidation, anti-tumor, and anti-virus functions (Yu et al., 2017), and inhibiting IL-1β and ICAM-1 by AM may lead to gout suppression in MSU-induced HUVECs (Chen et al., 2016a).